Rhonda Hellums - Chief Financial Officer at Silence Therapeutics plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
SLN on Nasdaq, SLNCF on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Rhonda Hellums since 1/9/2024

Holdings reported by Rhonda Hellums for Silence Therapeutics plc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Share Option (Right to Buy) 375K Jan 2, 2025 Direct Ordinary Shares
Ordinary Shares 1.5K Jan 2, 2025 Direct

Transactions reported by Rhonda Hellums for Silence Therapeutics plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.